Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials

Rhythm control with antiarrhythmic drugs (AADs) is not superior to rate control in patients with heart failure (HF) and atrial fibrillation (AF), but AF ablation may be more successful at achieving rhythm control than AADs. However, risks for both ablation and AADs are likely higher and success rate...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Clinical electrophysiology 2015-06, Vol.1 (3), p.200-209
Main Authors: Al Halabi, Shadi, Qintar, Mohammed, Hussein, Ayman, Alraies, M Chadi, Jones, David G, Wong, Tom, MacDonald, Michael R, Petrie, Mark C, Cantillon, Daniel, Tarakji, Khaldoun G, Kanj, Mohamed, Bhargava, Mandeep, Varma, Niraj, Baranowski, Bryan, Wilkoff, Bruce L, Wazni, Oussama, Callahan, Thomas, Saliba, Walid, Chung, Mina K
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rhythm control with antiarrhythmic drugs (AADs) is not superior to rate control in patients with heart failure (HF) and atrial fibrillation (AF), but AF ablation may be more successful at achieving rhythm control than AADs. However, risks for both ablation and AADs are likely higher and success rates lower in patients with HF. To compare rate control versus AF catheter ablation strategies in patients with AF and HF. We conducted a meta-analysis of trials which randomized HF patients (LVEF
ISSN:2405-500X
2405-5018
2405-500X
DOI:10.1016/j.jacep.2015.02.018